|| and the Gynecology Cancer Disease Site Groupultrasonography), there is currently no screening strategy for ovarian cancer.The purpose of this document is to identify evidence that would inform optimal recommended protocols for the identification and surgical management of adnexal masses suspicious for malignancy.
OutcomesOutcomes of interest for the identification question included sensitivity and specificity. Outcomes of interest for the surgical question included optimal surgery, overall survival, progression-free or diseasefree survival, reduction in the number of surgeries, morbidity, adverse events, and quality of life.
MethodologyAfter a systematic review, a practice guideline containing clinical recommendations relevant to patients in Ontario was drafted. The practice guideline was reviewed and approved by the Gynecology Disease Site Group and the Report Approval Panel of the Program in Evidence-based Care. External review by Ontario practitioners was obtained through a survey, the results of which were incorporated into the practice guideline.
Practice GuidelineThese recommendations apply to adult women presenting with a suspicious adnexal mass, either symptomatic or asymptomatic.
Identification of an Adnexal Mass Suspicious for Ovarian CancerSonography (particularly 3-dimensional sonography), magnetic resonance imaging (mri), and computed tomography (ct) imaging are each recommended for differentiating malignant from benign ovarian masses. However, the working group offers the following further recommendations, based on
ABSTRACT
QuestionsWhat is the optimal strategy for preoperative identification of the adnexal mass suspicious for ovarian cancer?What is the most appropriate surgical procedure for a woman who presents with an adnexal mass suspicious for malignancy?
PerspectivesIn Canada in 2010, 2600 new cases of ovarian cancer were estimated to have been diagnosed, and of those patients, 1750 were estimated to have died, making ovarian cancer the 7th most prevalent form of cancer and the 5th leading cause of cancer death in Canadian women. Women with ovarian cancer typically have subtle, nonspecific symptoms such as abdominal pain, bloating, changes in bowel frequency, and urinary or pelvic symptoms, making early detection difficult. Thus, most ovarian cancer cases are diagnosed at an advanced stage, when the cancer has spread outside the pelvis. Because of late diagnosis, the 5-year relative survival ratio for ovarian cancer in Canada is only 40%. Unfortunately, because of the low positive predictive value of potential screening tests (cancer antigen 125 and